WallStreetZenWallStreetZen

NASDAQ: FBLG
Fibrobiologics Inc Earnings & Revenue

FBLG earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$19.1M
Current Profit Margin
0%

FBLG Return on Equity

Insufficient data to display

Be the first to know when FBLG announces earnings.

FBLG Return on Assets

Current Company
-229%
Current Industry
2.9%
FBLG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FBLG Return on Capital Employed

Current Company
-619.33%
Current Industry
19.5%

FBLG vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FBLG$0.00-$15.90M-$19.06MN/AN/A
OCGN$6.04M-$61.84M-$63.08M+518.47%N/A
LXEO$0.00-$64.35M-$66.39M-100.00%N/A
RANI$0.00-$27.02M-$33.97M-100.00%N/A
CRBU$34.48M-$96.30M-$102.07M+56.22%N/A

Fibrobiologics Earnings & Revenue FAQ

What were FBLG's earnings last quarter?

Fibrobiologics (NASDAQ: FBLG) reported Q4 2023 earnings per share (EPS) of -$0.35, up 600% year over year. Total Fibrobiologics earnings for the quarter were -$9.72 million. In the same quarter last year, Fibrobiologics's earnings per share (EPS) was -$0.05.

If you're new to stock investing, here's how to buy Fibrobiologics stock.

What was FBLG's earnings growth in the past year?

As of Q2 2024, Fibrobiologics's earnings has grown year over year. Fibrobiologics's earnings in the past year totalled -$19.06 million.

What was FBLG's revenue last quarter?

Fibrobiologics (NASDAQ: FBLG) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Fibrobiologics's revenue was $0.00.

What was FBLG's revenue growth in the past year?

As of Q2 2024, Fibrobiologics's revenue has grown null year over year. Fibrobiologics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.